Thomas G. Gross

1.9k total citations
19 papers, 912 citations indexed

About

Thomas G. Gross is a scholar working on Oncology, Pathology and Forensic Medicine and Epidemiology. According to data from OpenAlex, Thomas G. Gross has authored 19 papers receiving a total of 912 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 6 papers in Pathology and Forensic Medicine and 6 papers in Epidemiology. Recurrent topics in Thomas G. Gross's work include Viral-associated cancers and disorders (12 papers), Cytomegalovirus and herpesvirus research (6 papers) and Lymphoma Diagnosis and Treatment (6 papers). Thomas G. Gross is often cited by papers focused on Viral-associated cancers and disorders (12 papers), Cytomegalovirus and herpesvirus research (6 papers) and Lymphoma Diagnosis and Treatment (6 papers). Thomas G. Gross collaborates with scholars based in United States, Japan and Netherlands. Thomas G. Gross's co-authors include E. Steve Woodle, Joseph F. Buell, Motohiko Okano, Angela Punnett, Barbara Savoldo, T M. Beebe, Michael J. Hanaway, M. Roy First, Rita R. Alloway and Jennifer Trofe and has published in prestigious journals such as New England Journal of Medicine, Blood and Biochemical and Biophysical Research Communications.

In The Last Decade

Thomas G. Gross

19 papers receiving 889 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas G. Gross United States 10 533 217 187 181 157 19 912
J S Najarian United States 15 429 0.8× 239 1.1× 327 1.7× 192 1.1× 237 1.5× 42 1.2k
B. Bourbigot France 16 344 0.6× 315 1.5× 402 2.1× 150 0.8× 659 4.2× 33 1.3k
E. Jeanne O'Sullivan United States 7 499 0.9× 228 1.1× 399 2.1× 137 0.8× 245 1.6× 11 953
Rajani Dinavahi United States 17 283 0.5× 111 0.5× 251 1.3× 65 0.4× 380 2.4× 37 976
Dominique Desvaux France 22 102 0.2× 156 0.7× 201 1.1× 98 0.5× 414 2.6× 43 1.0k
S Andresen United States 19 442 0.8× 88 0.4× 48 0.3× 128 0.7× 66 0.4× 35 998
Reggie Duerst United States 17 213 0.4× 85 0.4× 151 0.8× 91 0.5× 33 0.2× 42 902
GE Sale United States 11 549 1.0× 225 1.0× 98 0.5× 141 0.8× 41 0.3× 14 1.4k
Kimikazu Yakushijin Japan 19 278 0.5× 108 0.5× 63 0.3× 151 0.8× 52 0.3× 135 1.1k
Brian G. Engelhardt United States 19 208 0.4× 107 0.5× 124 0.7× 70 0.4× 72 0.5× 68 1.1k

Countries citing papers authored by Thomas G. Gross

Since Specialization
Citations

This map shows the geographic impact of Thomas G. Gross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas G. Gross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas G. Gross more than expected).

Fields of papers citing papers by Thomas G. Gross

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas G. Gross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas G. Gross. The network helps show where Thomas G. Gross may publish in the future.

Co-authorship network of co-authors of Thomas G. Gross

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas G. Gross. A scholar is included among the top collaborators of Thomas G. Gross based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas G. Gross. Thomas G. Gross is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Henderson, Marianne K., Osvaldo L. Podhajcer, Andrea S. Llera, et al.. (2020). The US–Latin America Cancer Research Network. JCO Global Oncology. 6(Supplement_1). 56–56. 2 indexed citations
2.
Minard‐Colin, Véronique, Anne Aupérin, Marta Pillon, et al.. (2020). Rituximab for High-Risk, Mature B-Cell Non-Hodgkin’s Lymphoma in Children. New England Journal of Medicine. 382(23). 2207–2219. 143 indexed citations
3.
Lyerly, H. Kim, Jun Ren, Renzo Canetta, et al.. (2018). Global Development of Anticancer Therapies for Rare Cancers, Pediatric Cancers, and Molecular Subtypes of Common Cancers. Journal of Global Oncology. 4(4). 1–11. 8 indexed citations
4.
Glotz, Denis, Jeremy R. Chapman, Vikas R. Dharnidharka, et al.. (2012). The Seville Expert Workshop for Progress in Posttransplant Lymphoproliferative Disorders. Transplantation. 94(8). 784–793. 37 indexed citations
5.
Gross, Thomas G., Amanda Termuhlen, Micah Skeens, et al.. (2011). Disseminated Rhizomucor pusillus Causing Early Multiorgan Failure During Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia. Journal of Pediatric Hematology/Oncology. 33(3). 235–237. 5 indexed citations
6.
7.
Gross, Thomas G., Barbara Savoldo, & Angela Punnett. (2010). Posttransplant Lymphoproliferative Diseases. Pediatric Clinics of North America. 57(2). 481–503. 32 indexed citations
8.
Mustillo, Peter, Rajinder Bajwa, Amanda Termuhlen, et al.. (2008). Tumor immune surveillance defect of X‐linked severe combined immunodeficiency is not Epstein–Barr virus specific. Pediatric Blood & Cancer. 51(5). 706–709. 4 indexed citations
9.
Okano, Motohiko & Thomas G. Gross. (2007). Advanced therapeutic and prophylactic strategies for Epstein–Barr virus infection in immunocompromised patients. Expert Review of Anti-infective Therapy. 5(3). 403–413. 16 indexed citations
10.
Buell, Joseph F., Thomas G. Gross, & E. Steve Woodle. (2005). Malignancy after Transplantation. Transplantation. 80(Supplement). S254–S264. 430 indexed citations
11.
Buell, Joseph F., Jennifer Trofe, Gopalan Sethuraman, et al.. (2003). Donors with central nervous system malignancies: are they truly safe?. Transplantation. 76(2). 340–343. 73 indexed citations
12.
Gross, Thomas G. & Brett Loechelt. (2003). Epstein–Barr virus associated disease following blood or marrow transplant. Pediatric Transplantation. 7(s3). 44–50. 6 indexed citations
13.
Gross, Thomas G., R. Maarten Egeler, & Franklin O. Smith. (2001). PEDIATRIC HEMATOPOIETIC STEM CELL TRANSPLANTATION. Hematology/Oncology Clinics of North America. 15(5). 795–808. 18 indexed citations
14.
Okano, Motohiko & Thomas G. Gross. (2001). FROM BURKITT'S LYMPHOMA TO CHRONIC ACTIVE EPSTEIN-BARR VIRUS (EBV) INFECTION: An Expanding Spectrum of EBV-Associated Diseases. Pediatric Hematology and Oncology. 18(7). 427–442. 9 indexed citations
15.
Gross, Thomas G., et al.. (2000). A Review of Epstein-Barr Virus Infection in Patients with Immunodeficiency Disorders. The American Journal of the Medical Sciences. 319(6). 392–396. 35 indexed citations
16.
Okano, Motohiko & Thomas G. Gross. (1996). Epstein-Barr virus-associated hemophagocytic syndrome and fatal infectious mononucleosis. American Journal of Hematology. 53(2). 111–115. 68 indexed citations
17.
Okano, Motohiko, Geoffrey M. Thiele, Thomas G. Gross, Jack R. Davis, & David T. Purtilo. (1990). Differential cellular susceptibility to Epstein‐Barr virus infection in a patient with X‐linked lymphoproliferative disease. Journal of Medical Virology. 32(1). 47–52. 9 indexed citations
18.
Gross, Thomas G., et al.. (1986). Transfer of the Epstein-Barr virus (EBV) DNA fragment coding for EBNA-1, the putative transforming antigen of EBV, into normal human lymphocytes: Gene expression without cell transformation. Biochemical and Biophysical Research Communications. 134(3). 1260–1268. 8 indexed citations
19.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J S Najarian Breakdown of academic impact, for papers by B. Bourbigot Breakdown of academic impact, for papers by E. Jeanne O'Sullivan Breakdown of academic impact, for papers by Rajani Dinavahi Breakdown of academic impact, for papers by Dominique Desvaux Breakdown of academic impact, for papers by S Andresen Breakdown of academic impact, for papers by Reggie Duerst Breakdown of academic impact, for papers by GE Sale Breakdown of academic impact, for papers by Kimikazu Yakushijin Breakdown of academic impact, for papers by Brian G. Engelhardt
Rankless by CCL
2026